ARTICLE | Company News
Signase, Tripos deal
May 6, 2002 7:00 AM UTC
The companies extended a deal to identify compounds that inhibit Src kinases. The deal combines Signase's protein kinase inhibitor chemistry technology with TRPS's LeadQuest chemical libraries and Ch...